Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2023, 32(1):43-48

European ESC/ESH versus American ACC/AHA Guidelines on the management of arterial hypertension: parallels and differences

Gašpar Ľ1, 2, Bulas J1, Wawruch M3, Murín J1
1 I. interná klinika LF UK a UN Bratislava
2 Fakulty zdravotníckych vied, UCM Trnava
3 Ústav farmakológie a klinickej farmakológie LF UK Bratislava, Slovenská republika

Both the European ESC/ESH and the American ACC/AHA Guidelines for the management of arterial hypertension are based on evidence-based medicine, the application of which is the first and basic prerequisite for the successful treatment of hypertension and the prevention of cardiovascular consequences. Although both Guidelines coincide in many thematic outputs (prevention, diagnostics), there are a fundamental differences between them. There is primarily a difference in the classification of blood pressure and the degree of hypertension: there are different opinions on the initiation of medical treatment, and in addition, each professional society proposes a different risk score to evaluate the cardiovascular risk in patients with hypertension. These differences make it very difficult to compare the results of epidemiological studies on the prevalence of different types of arterial hypertension and the effectiveness of treatment. Arterial hypertension is also a very real problem in the Slovak Republic, and therefore the implementation of the ESC/ESH Guidelines for the management of arterial hypertension in our clinical practice aims to increase the percentage of diagnosed hypertension, and to increase the number of already diagnosed hypertensives which reach safe blood pressure target values and the associated better long-term prognosis. Tab. 2, Ref. 11, on-line full text (Free, PDF) www.cardioloyletters.sk

Keywords: arterial hypertension; European and US Guidelines on the management of hypertension; comparison

Published: January 1, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gašpar Ľ, Bulas J, Wawruch M, Murín J. European ESC/ESH versus American ACC/AHA Guidelines on the management of arterial hypertension: parallels and differences. Cardiology Letters. 2023;32(1):43-48.
Download citation

References

  1. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Barnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021-3104. DOI: 10.1093/eurheart/ehy339 Go to original source...
  2. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002;40:795-796. DOI:10.1161/01. hyp.0000038733.08436.98 Go to original source...
  3. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999;131:564-572. DOI:10.7326/0003-4819-1318-199910190-00003 Go to original source...
  4. Magalhaes JA, Lins-Filho OL, Couto TLG, de FP Silva MV, Lustosa TC, Barroso WKS, et al. Prevalence of masked hypertension evaluated by home blood pressure monitoring in a large sample of patients with office blood pressure ˂ 140/90 mmHg. Blood Press Monit 2021;26:224-229. DOI:10.1097/MBP.0000000000000517 Go to original source...
  5. Pierdomenico SD, Pierdomenico AM, Coccina F, Porreca E. Prognosis of masked and white coat uncontrolled hypertension detected by Ambulatory blood pressure monitoring in elderly treated hypertensive patients. Am J Hypertens 2017;30:11061111. DOI:10.1093/ajh/hpx104 Go to original source...
  6. Aronow WS. Masked hypertension. Ann Transl Med 2017;5:456. DOI:10.21037/atm.2017.09.24 Go to original source...
  7. Thakkar HV, Pope A, Anpalahan M. Masked hypertension: A systematic review. Heart Lung and Circulation 2020;29:102-111. DOI:10.1016/j.hlc.2019.08.006 Go to original source...
  8. Li S, Schwartz JE, Shimbo D, Muntner P, Shikany JM, Booth 3rd JN, et al. Estimated prevalence of masked asleep hypertension in US adults. JAMA Cardiol 2021;6:568-573. DOI:10.1001/ jamacardio2020.5212 Go to original source...
  9. Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Himmelfarb ChD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71(62017):e13-e115. DOI:10.1161/HYP.0000000000000065 Go to original source...
  10. De la Sierra A, Banegas R, Vinyoles E, Segura J, Gorostidi M, de la Cruz J, et al. Prevalence of masked hypertension in untreated and treated patients with office blood pressure below 130/80 mmHg. Circulation 2018;137:2651-2653. DOI:10.1161/CIRCULATIONAHA.118.034619 Go to original source...
  11. Schwartz JE, Burg MM, Shimbo D, Broderick JE, Stone AA, Ishikawa J, et al. Clinic blood pressure underestimates ambulatory blood pressure in untreated employer-based US population: Results from the Masked Hypertension Study. Circulation 2016;134:1794-1807. DOI:10.1161/CIRCULATIONAHA.116.023404 Go to original source...
  12. Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, et al. Target organ complications and cardiovascular events associated with masked hypertension and whitecoat hypertension: analysis from the Dallas Heart Study. J Am Coll Cardiol 2015;66:2159-2169. DOI:10.1016/j. jacc.2015.09.007 Go to original source...
  13. Omboni S, Aristizabal, D, de la Sierra A, Dolan E, Head G, Kahan T, et al. Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study. J Hypertens. 2016;34:2187-2198. DOI:10.1097/HJH.0000000000001074 Go to original source...
  14. Presta V, Figliuzzi I, D´Agostino M, Citoni B, Miceli F, Simonelli F, et al. Nocturnal blood pressure patterns and cardiovascular outcomes in patients with masked hypertension. J Clin Hypertens (Greenwich). 2018;20:1238-1246. DOI:10.1111/jch.13361 Go to original source...
  15. Aronow WS. Hypertension and left ventricular hypertrophy. Ann Transl Med 2017;5:310. DOI:10.21037atm.2017.06.14 Go to original source...
  16. Pierdomenico SD, Pierdomenico AM, Coccina F, Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of masked uncontrolled hypertension: systematic review and meta-analysis. Hypertension 2018;72:862-869. DOI:10.1161/ HYPERTENSIONAHA.118.11499 Go to original source...
  17. Zhang DY, Guo QH, De-Wei A, Li Y, Wang J-G. A comparative meta-analysis of prospective observational studies on masked hypertension and masked uncontrolled hypertension defined by ambulatory and home blood pressure. J Hypertens2019;37:1775-1785. DOI:10.1097/HJH.0000000000002109 Go to original source...
  18. Van Vark LC, Bertrand M, Akkerhuis M, Brugts JJ, Fox K, Mourad J-J, el. al. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients. Eur Heart J 2012;33:2088-2097. DOI:10.1093/eurheartj/ehs075 Go to original source...